Conference
Advertisement
Advertisement
Trending on Urology Times
1
Alicia Morgans, MD, MPH, highlights key prostate cancer data from ESMO 2026
2
Updated CAPItello-281 data show numerical OS benefit with capivasertib in PTEN-deficient mHSPC
3
LITESPARK-012: Lessons from a negative phase 3 trial in first-line RCC
4
ESMO 2026 recap: Notable updates across genitourinary oncology
5